At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 48 enrolled
Drug / intervention
Miracle Fruitdrug
Likely dose
Miracle Fruit 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy
In Brief
A Early Phase 1 clinical trial evaluating Miracle Fruit for Taste, Altered and Dysgeusia. Completed, enrolled 48 participants.
Detailed Summary
Purpose and Objective: Compare the incidence of taste alteration in treatment vs. control arms and Compare weight loss in treatment vs. control arms
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTaste, Altered, Dysgeusia
Countries--
Collaborators--
Timeline
Early Ph 1CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
Primary CompletionJun 2011
First PostedNov 2020
TodayJul 2026
First PostedNov 16, 2020
Enrollment StartAug 18, 2008
Primary CompletionJun 20, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 5.6 years ago
Interventions
Miracle Fruitdrug
one miracle fruit tablet of 100 mg 10-15 minutes before lunch and dinner versus supportive measures. Patients assigned to receive the miracle fruit will receive written instructions regarding the use of the fruit. Patients should put the fruit tablet or powder in the mouth and gently chew/suck to dissolve and cover the tongue with the powder